BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19560699)

  • 1. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.
    Kittleson MM; Skojec DV; Wittstein IS; Champion HC; Judge DP; Barouch LA; Halushka M; Hare JM; Kasper EK; Russell SD
    J Heart Lung Transplant; 2009 Jul; 28(7):704-9. PubMed ID: 19560699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements.
    Wu AH; Johnson ML; Aaronson KD; Gordon D; Dyke DB; Koelling TM
    J Heart Lung Transplant; 2005 Jan; 24(1):52-7. PubMed ID: 15653379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection.
    Avello N; Molina BD; Llorente E; Bernardo MJ; Prieto B; Alvarez FV
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):182-8. PubMed ID: 17362585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation.
    Garrido IP; Pascual-Figal DA; Nicolás F; González-Carrillo MJ; Manzano-Fernández S; Sánchez-Mas J; Valdés-Chavarri M
    Am J Cardiol; 2009 Apr; 103(8):1149-53. PubMed ID: 19361605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients.
    O'Neill JO; McRae AT; Troughton RW; Ng K; Taylor DO; Yamani MH; Young JB; Starling RC
    J Heart Lung Transplant; 2005 Apr; 24(4):416-20. PubMed ID: 15797742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of NT-proBNP determinations in the follow-up of heart transplantation.
    Cuppoletti A; Roig E; Pérez-Villa F; Marin JL; Orús J; Vallejos I; Rivera A; Botta C
    Transplant Proc; 2005 Nov; 37(9):4033-5. PubMed ID: 16386619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.
    Bader FM; Rogers RK; Kfoury AG; Gilbert EM; Horne BD; Stehlik J; Renlund DG
    Congest Heart Fail; 2009; 15(2):63-7. PubMed ID: 19379451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine profiling of humans receiving cardiac allografts.
    Ogawa T; Veinot JP; Davies RA; Haddad H; Smith SJ; Masters RG; Hendry PJ; Starling R; de Bold MK; Ponce A; Ma KK; Williams K; de Bold AJ
    J Heart Lung Transplant; 2005 Aug; 24(8):1046-54. PubMed ID: 16102440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation].
    Yin D; Huang J; Feng L; Feng GX; Hu SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.
    Hammerer-Lercher A; Mair J; Antretter H; Ruttmann E; Poelzl G; Laufer G; Puschendorf B; Hangler H
    J Heart Lung Transplant; 2005 Sep; 24(9):1444. PubMed ID: 16143273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
    Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
    Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection.
    Arnau-Vives MA; Almenar L; Hervas I; Osa A; Martinez-Dolz L; Rueda J; Zorio E; Martinez-Ortiz De Urbina L; Perez JL; Mateo A; Palencia M
    J Heart Lung Transplant; 2004 Jul; 23(7):850-6. PubMed ID: 15261180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients.
    Rossano JW; Denfield SW; Kim JJ; Price JF; Jefferies JL; Decker JA; Smith EO; Clunie SK; Towbin JA; Dreyer WJ
    J Heart Lung Transplant; 2008 Jun; 27(6):649-54. PubMed ID: 18503965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction.
    Drewniak W; Snopek G; Zarukiewicz M; Borys M; Dabrowski M
    Kardiol Pol; 2008 Jul; 66(7):750-5; discussion 756-7. PubMed ID: 18690566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.